rs1036332

GWAS Catalog Trait Associations (21)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

eosinophil count

Allele C
OR
p 3.0e-50
N 583,850
Large GWAS
multi-ancestry
Sakaue S et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nature Genetics 53(10):1415-1424 (2021)
Allele C
OR 0.02
p 3.0e-35
N 442,919
Large GWAS
multi-ancestry
Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele C
OR 0.03
p 2.0e-40
N 408,112
Large GWAS
European
Allele C
OR 0.03
p 1.0e-30
N 394,642
Large GWAS
European
Allele C
OR 0.04
p 1.0e-20
N 172,275
Large GWAS
European

eosinophil percentage of leukocytes

Allele C
OR 0.03
p 2.0e-38
N 394,642
Large GWAS
European
Allele C
OR 0.04
p 1.0e-20
N 172,378
Large GWAS
European

roundabout homolog 1 measurement

Allele C
OR 0.07
p 4.0e-36
N 47,745
Large GWAS
European

cochlin measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele A
OR 0.16
p 6.0e-27
N 10,708
Large GWAS
European

reticulocyte count

Allele C
OR 0.02
p 7.0e-22
N 394,642
Large GWAS
European

basophil count, eosinophil count

Allele C
OR 0.04
p 4.0e-21
N 171,771
Large GWAS
European

platelet volume

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele C
OR 0.02
p 2.0e-19
N 408,112
Large GWAS
European

eosinophil percentage of granulocytes

Allele C
OR 0.03
p 2.0e-17
N 170,536
Large GWAS
European

neutrophil percentage of granulocytes

Allele C
OR 0.03
p 7.0e-17
N 170,672
Large GWAS
European

level of prorelaxin H2 in blood

Allele C
OR 0.05
p 8.0e-12
N 47,745
Large GWAS
European

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…